Ionis Pharmaceuticals: 2Q Earnings Snapshot
CARLSBAD, Calif. (AP) _ Ionis Pharmaceuticals Inc. (IONS) on Wednesday reported a loss of $1 million in its second quarter.
The Carlsbad, California-based company said it had a loss of 1 cent per share.
The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 27 cents per share.
The drug discovery and development company posted revenue of $164 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $140.8 million.
Ionis Pharmaceuticals shares have increased 19% since the beginning of the year. The stock has climbed 47% in the last 12 months.